Citations (24)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (2)
Ameenathul M. Fawzy, Wang-Yang Yang & Gregory YH. Lip. (2019) Safety of direct oral anticoagulants in real–world clinical practice: translating the trials to everyday clinical management. Expert Opinion on Drug Safety 18:3, pages 187-209.
Read now
Read now
Andrea Cervi & Mark Crowther. (2018) Andexanet alfa for the treatment of hemorrhage. Expert Review of Hematology 11:11, pages 847-855.
Read now
Read now
Articles from other publishers (22)
Eric Rytkin, Irina V. Bure, Pavel O. Bochkov, Kristina A. Akmalova, Karin B. Mirzaev, Marina S. Cherniaeva, Olga D. Ostroumova, Valery V. Smirnov, Elena A. Grishina, Anna G. Saribekian, Igor N. Sychev & Dmitry A. Sychev. (2022) MicroRNAs as novel biomarkers for rivaroxaban therapeutic drug monitoring. Drug Metabolism and Personalized Therapy 37:1, pages 41-46.
Crossref
Crossref
Shannon Kuhrau, Dalila Masic, Erin Mancl, Yevgeniy Brailovsky, Katerina Porcaro, Stephen Morris, Jeremiah Haines, Kim Charo, Jawed Fareed & Amir Darki. (2020) Impact of Pulmonary Embolism Response Team on Anticoagulation Prescribing Patterns in Patients With Acute Pulmonary Embolism. Journal of Pharmacy Practice 35:1, pages 38-43.
Crossref
Crossref
Pallavi Dev, Carol Abousaab, Cecilia Zhou & Ravi Sarode. (2021) Efficacy of prothrombin complex concentrate in the management of oral factor Xa inhibitors associated major bleed assessed by ISTH and ANNEXA-4 criteria. Journal of Thrombosis and Thrombolysis 53:2, pages 249-256.
Crossref
Crossref
Carlos GalhardoJr.Jr., Luiz Henrique Ide Yamauchi, Hugo Dantas & João Carlos de Campos Guerra. (2021) Clinical protocols for oral anticoagulant reversal during high risk of bleeding for emergency surgical and nonsurgical settings: a narrative review. Brazilian Journal of Anesthesiology (English Edition) 71:4, pages 429-442.
Crossref
Crossref
Sarah E. Nelson, Robert P. Giugliano, Elliott M. Antman, Jeong-Gun Park, Andrew D. Norden, Natalia S. Rost, Scott Silverman, Aneesh B. Singhal, Hans J. Lanz, Eugene Braunwald & Christian T. Ruff. (2021) Intracranial hemorrhage in patients with atrial fibrillation receiving anticoagulation with warfarin or edoxaban: An in-depth analysis from the ENGAGE AF-TIMI 48 randomized trial. Journal of Clinical Neuroscience 86, pages 294-300.
Crossref
Crossref
Maria Giulia Mosconi, Maurizio Paciaroni, Giancarlo Agnelli, Martino Marzano, Andrea Alberti, Michele Venti, Monica Acciarresi, Fabrizio Ruffini & Valeria Caso. (2020) SMASH-U classification: a tool for aetiology-oriented management of patients with acute haemorrhagic stroke. Internal and Emergency Medicine 16:1, pages 109-114.
Crossref
Crossref
Truman J. Milling & Charles V. Pollack. (2020) A review of guidelines on anticoagulation reversal across different clinical scenarios – Is there a general consensus?. The American Journal of Emergency Medicine 38:9, pages 1890-1903.
Crossref
Crossref
N. S. Lapina, A. A. Alekseeva, A. D. Vershinina, N. S. Khruleva, F. N. Muradova & L. Y. Koroleva. (2020) Gastrointestinal Bleeding in Antithrombotic Therapy in Patients with Coronary Heart Disease: Risk Factors, Pathogenesis and Treatment. Russian Journal of Gastroenterology, Hepatology, Coloproctology 30:3, pages 14-23.
Crossref
Crossref
Johannes Daniël Cnossen, Jeannette Fenna Schoonderbeek & Maaike Muller. (2020) Spontaneous Sublingual Haematoma in a 90-year Old Patient: A Complication of Direct Oral Anticoagulants. The Journal of Critical Care Medicine 6:2, pages 111-114.
Crossref
Crossref
Douglas L. Jennings, Jessica Rimsans & Jean M. Connors. (2020) Prothrombin Complex Concentrate for Warfarin Reversal in Patients with Continuous-Flow Left Ventricular Assist Devices: A Narrative Review. ASAIO Journal 66:5, pages 482-488.
Crossref
Crossref
Vikram A. Mehta, Timothy Y. Wang, Eric W. Sankey, Elizabeth P. Howell, C. Rory Goodwin, Jerrold H. Levy & Allan H. Friedman. (2020) Restarting Therapeutic Anticoagulation After Elective Craniotomy for Patients with Chronic Atrial Fibrillation: A Review of the Literature. World Neurosurgery 137, pages 130-136.
Crossref
Crossref
Rick Meinig, Stephanie Jarvis, Alessandro Orlando, Nnamdi Nwafo, Rahul Banerjee, Patrick McNair, Bradley Woods, Paul Harrison, Michelle Nentwig, Michael Kelly, Wade Smith & David Bar-Or. (2020) Is anticoagulation reversal necessary prior to surgical treatment of geriatric hip fractures?. Journal of Clinical Orthopaedics and Trauma 11, pages S93-S99.
Crossref
Crossref
Marwan Sheikh-Taha. (2018) Idarucizumab for Reversal of Dabigatran: Single-Center Real-World Experience. American Journal of Cardiovascular Drugs 19:1, pages 59-64.
Crossref
Crossref
Mohammad Hamidi, Muhammad Zeeshan, Joseph V. Sakran, Narong Kulvatunyou, Terence O’Keeffe, Ashley Northcutt, El Rasheid Zakaria, Andrew Tang & Bellal Joseph. (2019) Direct Oral Anticoagulants vs Low-Molecular–Weight Heparin for Thromboprophylaxis in Nonoperative Pelvic Fractures. Journal of the American College of Surgeons 228:1, pages 89-97.
Crossref
Crossref
Ameenathul M. Fawzy & Gregory Y.H. Lip. (2019) Anticoagulation in elderly patients with nonvalvular atrial fibrillation: A balancing act. Heart Rhythm 16:1, pages 38-40.
Crossref
Crossref
Joshua Heiman, Tim Large & Amy Krambeck. (2018) Best practice in the management of benign prostatic hyperplasia in the patients requiring anticoagulation. Therapeutic Advances in Urology 10:12, pages 431-436.
Crossref
Crossref
Thomas A. Verbeek, Jonathan G. Stine, Fuat H. Saner & Dmitri Bezinover. (2018) Hypercoagulability in End-stage Liver Disease: Review of Epidemiology, Etiology, and Management. Transplantation Direct 4:11, pages e403.
Crossref
Crossref
Juan Pablo Salazar Adum, Iva Golemi, Luis H. Paz, Luis Diaz Quintero, Alfonso J. Tafur & Joseph A. Caprini. (2018) Venous thromboembolism controversies. Disease-a-Month 64:9, pages 408-444.
Crossref
Crossref
C. Bensi, S. Belli, D. Paradiso & G. Lomurno. (2018) Postoperative bleeding risk of direct oral anticoagulants after oral surgery procedures: a systematic review and meta-analysis. International Journal of Oral and Maxillofacial Surgery 47:7, pages 923-932.
Crossref
Crossref
Donal J. Sexton, Declan G. de Freitas, Mark A. Little, Tomas McHugh, Colm Magee, Peter J. Conlon & Conall M. O’Seaghdha. (2018) Direct-Acting Oral Anticoagulants as Prophylaxis Against Thromboembolism in the Nephrotic Syndrome. Kidney International Reports 3:4, pages 784-793.
Crossref
Crossref
Silvia Calabria, Emanuele Forcesi, Letizia Dondi, Antonella Pedrini, Aldo Pietro Maggioni & Nello Martini. (2018) Target Population of Non-deferrable Surgery and Uncontrolled Severe Bleeding Related to Dabigatran. Cardiovascular Drugs and Therapy 32:3, pages 281-286.
Crossref
Crossref
Radovan Malý. (2018) Optimal treatment of venous thromboembolism. Medicína pro praxi 15:1, pages 26-29.
Crossref
Crossref